Quince Therapeutics, Inc. — Form D

Quince Therapeutics, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-07-01. The offering totals $21.9M, of which $11.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Luca BenattiDirectorSouth San Francisco, CA
June BrayDirectorSouth San Francisco, CA
David LamondDirectorSouth San Francisco, CA
Margi McLoughlinDirectorSouth San Francisco, CA
Rajiv PatniDirectorSouth San Francisco, CA
Una RyanDirectorSouth San Francisco, CA
Christopher SennerDirectorSouth San Francisco, CA
Dirk ThyeDirectorSouth San Francisco, CA
Brendan HannahExecutive OfficerSouth San Francisco, CA
Charles RyanExecutive OfficerSouth San Francisco, CA
Dirk ThyeExecutive OfficerSouth San Francisco, CA
CASEY LYNCHDirectorBOISE, ID
CASEY LYNCHExecutive OfficerBOISE, ID
David LamondRelated PersonSouth San Francisco, CA
Christopher SennerRelated PersonSouth San Francisco, CA
Charles RyanRelated PersonSouth San Francisco, CA
June BrayRelated PersonSouth San Francisco, CA
Brendan HannahRelated PersonSouth San Francisco, CA
Dirk ThyeRelated PersonSouth San Francisco, CA
Ilan ZipkinDirectorOAKLAND, CA
Roger QuyDirectorSouth San Francisco, CA
Kristen GafricExecutive OfficerSouth San Francisco, CA
Stephen DominyDirectorNOVATO, CA
Stephen A DominyDirectorSouth San Francisco, CA
Ilan A ZipkinDirectorBelmont, CA

Other filings by this issuer (5)

FiledFormOfferingSold
2026-06-11D$186.4M$114.7M
2026-06-11D$7.4M
2018-05-31D$85.6M$84.5M
2017-02-14D$8.0M$7.6M
2016-01-05D$15.9M$7.9M

More